Voice disorders caused by neurological diseases

被引:12
|
作者
Gamboa, J
Jiménez-Jiménez, FJ
Mate, MA
Cobeta, I
机构
[1] Univ Alcala de Henares, Serv Otorrinolaringol, Hosp Principe Asturias, E-28805 Madrid, Spain
[2] Univ Alcala de Henares, Dept Med Neurol, Hosp Principe Asturias, E-28805 Madrid, Spain
关键词
acoustic analysis; aerodynamic measures; laryngeal electromyography; neurological disease; phonetometric measures; voice disturbances;
D O I
10.33588/rn.3302.2001151
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective. To review voice disorders in neurological diseases, with special emphasis to acoustic analysis. Development In the first part of this article we describe data regarding neural control of voice, physiology of phonation, and examination of the patient with voice disturbances, including the use of voice laboratory, acoustic analysis fundamentals, phonetometric measures and aerodynamic measures. In the second part, we review the voice disturbances associated to neurological diseases, emphasizing into movement disorders (specially Parkinson's disease, essential tremor, and spasmodic dysphonia). Conclusions. A number of neurological diseases causing alterations of corticospinal pathway, cerebellum, basal ganglia and upper andlor lower motoneurons can induce voice disturbances. Voice examination using ear, nose & throat examination, endoscopy and videorecording of laryngeal movements, acoustic analysis, elecroglottography, laryngeal electromyography, and aerodynamic measures, could be useful in the clinical examination of some neurological diseases.
引用
收藏
页码:153 / 168
页数:16
相关论文
共 50 条
  • [41] Automatic classification of neurological voice disorders using wavelet scattering features
    Yagnavajjula, Madhu Keerthana
    Mittapalle, Kiran Reddy
    Alku, Paavo
    Rao, K. Sreenivasa
    Mitra, Pabitra
    SPEECH COMMUNICATION, 2024, 157
  • [42] VOICE ANALYSIS OF PATIENTS WITH NEUROLOGICAL DISORDERS USING ACOUSTICAL AND NONLINEAR TOOLS
    Dajer, M. E.
    Scalassara, P. R.
    Marrara, J. L.
    Pereira, J. C.
    2012 IEEE INTERNATIONAL WORKSHOP ON MACHINE LEARNING FOR SIGNAL PROCESSING (MLSP), 2012,
  • [43] Neurological disorders caused by inherited ion-channel mutations
    Kullmann, DM
    Hanna, MG
    LANCET NEUROLOGY, 2002, 1 (03): : 157 - 166
  • [44] Translational research on cognitive and behavioural disorders in neurological and psychiatric diseases
    Corvol, Jean-Christophe
    Goni, Sylvia
    Bordet, Regis
    Azuar, Carole
    Blin, Olivier
    Checler, Frederic
    David, Denis J.
    Durif, Franck
    Fernagut, Pierre-Olivier
    Dupouey, Julien
    Otten, Lisa
    Gaillard, Raphael
    Kemel, Marie-Louise
    Micallef, Joelle
    Perault-Pochat, Marie-Christine
    Pitel, Anne-Lise
    Truffinet, Philippe
    THERAPIE, 2016, 71 (01): : 15 - 26
  • [45] Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
    Katrina J. Falkenberg
    Ricky W. Johnstone
    Nature Reviews Drug Discovery, 2015, 14 : 219 - 219
  • [46] The CBANCH report - The burden of neurological diseases, disorders, and injuries in Canada
    Tator, Charles
    Bray, Garth
    Morin, Dan
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2007, 34 (03) : 268 - 269
  • [47] Soft Implantable Bioelectronics for the Management of Neurological Disorders and Cardiovascular Diseases
    Kim, Hye Jin
    Sunwoo, Sung-Hyuk
    Koo, Ja Hoon
    Kim, Dae-Hyeong
    KOREAN JOURNAL OF CHEMICAL ENGINEERING, 2024,
  • [48] Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural Disorders
    Sanchez-Barcelo, Emilio J.
    Rueda, Noemi
    Mediavilla, Maria D.
    Martinez-Cue, Carmen
    Reiter, Russel J.
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (35) : 3851 - 3878
  • [49] The impact of mood disorders in neurological diseases: should neurologists be concerned?
    Kanner, AM
    Barry, JJ
    EPILEPSY & BEHAVIOR, 2003, 4 : S3 - S13
  • [50] Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
    Katrina J. Falkenberg
    Ricky W. Johnstone
    Nature Reviews Drug Discovery, 2014, 13 : 673 - 691